Liver Disease
News
FDA issues strong warning about oral ketoconazole
News
Coinfection with chronic hepatitis C and occult hepatitis B related to poor outcomes
Major finding: Among chronic hepatitis patients followed for a median of 11 years, 19% developed hepatocellular carcinoma.
News
Boceprevir an option for patients with HIV and HCV
Major finding: At follow-up week 24, 63% of patients in the boceprevir group achieved sustained virological response, compared with 29% of...
News
FDA approves first hepatitis C genotype test
News
Nosocomial infection in cirrhotic patients boosts acute kidney injury risk
Major finding: Nosocomial infections were associated with length of stay (odds ratio, 23.34 per day) and acute kidney injury (odds ratio, 2.82)....
News
Simeprevir keeps HCV at bay in treatment-naive and experienced patients
Major finding: SVR 12 rates were 81.3% in treatment-naive patients with HCV genotype 1 treated with simeprevir/pegylated interferon/ribavirin, and...
Conference Coverage
After HCV treatment failure, some success with boceprevir-IFN-ribavirin
Major finding: Among patients with hepatitis C infections who did not have a sustained virologic response after prior therapy, 63% had an SVR for...
News
Several blood tests can identify fibrosis in HCV
Major finding: Simple platelet counts, the age-platelet index, the APRI, the FibroIndex, the FibroTest, and the Forns index all were moderately...
From the AGA Journals
Augmentin implicated in drug-induced liver injury
Major finding: Drug-induced liver injury has an incidence of 19.1 per 100,000 persons, with the incidence per outpatient users of amoxicillin-...
From the AGA Journals
High mortality seen in acute-on-chronic liver failure
Major finding: Acute-on-chronic liver failure syndrome can be divided into three classes and is distinct from acute decompensation of chronic...